May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Characterization of Hemicentin
Author Affiliations & Notes
  • D.W. Schultz
    Ophthalmology, Casey Eye Inst Oregon Hth Sci, Portland, OR
  • K.A. Cox
    Ophthalmology, Casey Eye Inst Oregon Hth Sci, Portland, OR
  • J.M. Bradley
    Ophthalmology, Casey Eye Inst Oregon Hth Sci, Portland, OR
  • Y. Chen
    Ophthalmology, Casey Eye Inst Oregon Hth Sci, Portland, OR
  • A.M. Anderssohn
    Ophthalmology, Casey Eye Inst Oregon Hth Sci, Portland, OR
  • T.S. Acott
    Ophthalmology, Casey Eye Inst Oregon Hth Sci, Portland, OR
  • Footnotes
    Commercial Relationships  D.W. Schultz, None; K.A. Cox, None; J.M. Bradley, None; Y. Chen, None; A.M. Anderssohn, None; T.S. Acott, None.
  • Footnotes
    Support  Foundation Fighting Blindness, Fight for Sight, RPB and NEI #EY010572
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 3065. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.W. Schultz, K.A. Cox, J.M. Bradley, Y. Chen, A.M. Anderssohn, T.S. Acott; Characterization of Hemicentin . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3065.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To characterize the hemicentin protein and transcripts. Previously, a glutamine to arginine mutation was found in a conserved calcium–binding epidermal growth factor (cb–EGF) domain of hemicentin in affected members of a large family with age–related macular degeneration (AMD). To begin investigating the role of this hemicentin mutation in AMD, we evaluated its localization within the retina, protein expression and sizes on gels and alternative splicing of transcripts. Methods: Four peptide antibodies to amino acids, 72–118, 1342–1382, 2654–2697, and 5572–5609 of hemicentin were generated in rabbits. Confocal immunohistochemistry was used to localize hemicentin within cryosectoins of human retina and in retinal pigment epithelial (RPE) and skin fibroblast cell cultures. Western immunoblots and immunoprecipitation were used to determine approximate protein sizes and expression. RT–PCR, DNA sequencing, and BLAST searches were used to identify and map alternative transcripts in human skin fibroblasts and RPE. Results: Western blots of cellular extracts and of immunoprecipitates from cellular extracts with all four antibodies showed a band at around 600 kDa and several smaller apparent breakdown products. Immunohistochemistry of tissue suggests the presence of hemicentin in the RPE, in Bruch's membrane, around choroidal blood vessels and microcapillaries. Immunostaining was also present at lower levels throughout the retina and choroid and more abundant in the nerve fiber layer. In cell cultures, extracellular and cell surface staining was punctate and fibrillar. Perinuclear and cytoplasmic staining was also apparent. Alternative splicing of exon 104 is present in most tissues and alternative transcription start sites are seen at low levels. Conclusions: Hemicentin is expressed in several retinal and other tissues and appears to be predominantly, but not exclusively, an extracellular protein. Alternative transcript forms are expressed in the several tissues evaluated.

Keywords: age-related macular degeneration • immunohistochemistry • protein structure/function 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.